Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Mitchell

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
The Australasian Journal of Dermatology|January 20, 2018
Retrospective audit of patients referred for further treatment following Mohs surgery for non-melanoma skin cancerEdmund Wee, Michelle S Goh, Vanessa Estall, et al.
Journal of Imaging|December 24, 2025
Applying Radiomics to Predict Outcomes in Patients with High-Grade Retroperitoneal Sarcoma Treated with Preoperative RadiotherapyAdel Shahnam, Nicholas Hardcastle, David E Gyorki, et al.
Cell Cycle (Georgetown, Tex.)|May 10, 2013
Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent mannerSue Haupt, Catherine Mitchell, Vincent Corneille, et al.
Journal of Surgical Oncology|October 21, 2020
Characterising the immune microenvironment in liposarcoma, its impact on prognosis and the impact of radiotherapyHayden Snow, Catherine Mitchell, Shona Hendry, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 22, 2021
Appendiceal pseudomyxoma peritonei: predictors of recurrence and iterative surgeryJoseph C Kong, Michael P Flood, Glen R Guerra, et al.
Physics and Imaging in Radiation Oncology|March 14, 2022
A statistical, voxelised model of prostate cancer for biologically optimised radiotherapyRobert N Finnegan, Hayley M Reynolds, Martin A Ebert, et al.
Molecular Imaging and Biology|June 19, 2025
Poor Diagnostic Performance of the Melanin-Binding Tracer [18 F]MEL050 in Human Melanoma Indicates Biological HeterogeneityRobert E Ware, Damien Kee, Peter Roselt, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 31, 2019
The role of <sup>18</sup>F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!Te-Jui Hung, Luke McLean, Catherine Mitchell, et al.
BMC Urology|October 29, 2020
Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case reportScott G Williams, Han Xian Aw Yeang, Catherine Mitchell, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 5, 2020
SFRP4 drives invasion in gastric cancer and is an early predictor of recurrenceRita A Busuttil, Joshy George, Colin M House, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
The Australasian Journal of Dermatology|January 20, 2018
Retrospective audit of patients referred for further treatment following Mohs surgery for non-melanoma skin cancerEdmund Wee, Michelle S Goh, Vanessa Estall, et al.
Journal of Imaging|December 24, 2025
Applying Radiomics to Predict Outcomes in Patients with High-Grade Retroperitoneal Sarcoma Treated with Preoperative RadiotherapyAdel Shahnam, Nicholas Hardcastle, David E Gyorki, et al.
Cell Cycle (Georgetown, Tex.)|May 10, 2013
Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent mannerSue Haupt, Catherine Mitchell, Vincent Corneille, et al.
Journal of Surgical Oncology|October 21, 2020
Characterising the immune microenvironment in liposarcoma, its impact on prognosis and the impact of radiotherapyHayden Snow, Catherine Mitchell, Shona Hendry, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 22, 2021
Appendiceal pseudomyxoma peritonei: predictors of recurrence and iterative surgeryJoseph C Kong, Michael P Flood, Glen R Guerra, et al.
Physics and Imaging in Radiation Oncology|March 14, 2022
A statistical, voxelised model of prostate cancer for biologically optimised radiotherapyRobert N Finnegan, Hayley M Reynolds, Martin A Ebert, et al.
Molecular Imaging and Biology|June 19, 2025
Poor Diagnostic Performance of the Melanin-Binding Tracer [18 F]MEL050 in Human Melanoma Indicates Biological HeterogeneityRobert E Ware, Damien Kee, Peter Roselt, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 31, 2019
The role of <sup>18</sup>F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!Te-Jui Hung, Luke McLean, Catherine Mitchell, et al.
BMC Urology|October 29, 2020
Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case reportScott G Williams, Han Xian Aw Yeang, Catherine Mitchell, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 5, 2020
SFRP4 drives invasion in gastric cancer and is an early predictor of recurrenceRita A Busuttil, Joshy George, Colin M House, et al.
Pageof 12